Search | IOVS | ARVO Journals

View

Showing 1 – 10 of 10

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract May 2006

Antibiotic Resistances of Bacteria Identified in an Endophthalmitis Prospective Study

M. Passemard; P.O. Lafontaine; A. Pechinot; P.L. Cornut; F. Rouberol; J.P. Romanet; A.M. Bron; C. Garcher–Creuzot; C. Chiquet

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):5292. doi:

ARVO Annual Meeting Abstract May 2006

Prospective Randomized Clinical Trial Comparing Five–Day Face Down Position and Semi Seated Position After Surgery for Idiopathic Full–Thickness Macular Hole (MH): Preliminary Results

A. Guillaubey; P.O. Lafontaine; L. Malvitte; I. Hubert; A.M. Bron; J.P. Berrod; C. Creuzot–Garcher

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):1458. doi:

ARVO Annual Meeting Abstract May 2005

Anterior Chamber Paracentesis in the Treatment of Acute Elevation of Intraocular Pressure

F. Robichon; S. Arnavielle; L. Malvitte; A. Guillaubey; P.O. Lafontaine; C. Garcher–Creuzot; A.M. Bron

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):106. doi:

ARVO Annual Meeting Abstract May 2005

Comparison of Corneal Endothelium Changes After Trabeculectomy and Deep Sclerectomy

S. Arnavielle; P.O. Lafontaine; S. Bidot; A. Guillaubey; P. D'Athis; C. Creuzot–Garcher; A.M. Bron

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):128. doi:

ARVO Annual Meeting Abstract May 2005

TFF1, MUC5AC and HLA–DR Expression by Conjunctival Cells in Chronically Treated Glaucomatous Patients. Could These Markers Predict the Success of Antiglaucomatous Surgery?

C. Garcher; N. Buron; P.O. Lafontaine; M. Souchier; S. Arnavielle; E. Solary; F. Brignolle; C. Baudouin; A.M. Bron

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):63. doi:

ARVO Annual Meeting Abstract May 2005

Complications of Pars Plana Vitrectomy in Acute Endophthalmitis

P.O. Lafontaine; F. Rouberol; P.L. Cornut; A.M. Bron; G. Thuret; J.P. Romanet; C. Creuzot–Garcher; C. Chiquet

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):5489. doi:

ARVO Annual Meeting Abstract May 2004

Assessment of ocular surface during graft versus host disease. Clinical and biological assessment of clinical score such as Schirmer 1, Schirmer 2, BUT and patient subjective discomfort, and biological peptide secretion of HLA–DR, MUC5AC and TFF1

P.O. Lafontaine; F. Brignolle–Baudouin; N. Buron; E. Solary; C. Baudouin; A.M. Bron; C. Garcher–Creuzot

Invest. Ophthalmol. Vis. Sci.. 2004; 45(13):133. doi:

ARVO Annual Meeting Abstract May 2004

Clinical and biological assessment of ocular surface disorders in patients with Sjögrens

M.D. M. Soulie; F. Brignolle–Baudouin; L. Malvitte; P.O. Lafontaine; A.M. Bron; C. Garcher–Creuzot

Invest. Ophthalmol. Vis. Sci.. 2004; 45(13):85. doi:

ARVO Annual Meeting Abstract May 2004

Apoptosis induced by UV and benzalkonium chloride in Chang conjunctival cells

C. Garcher; N. Buron; P.O. Lafontaine; E. Solary

Invest. Ophthalmol. Vis. Sci.. 2004; 45(13):1497. doi:

ARVO Annual Meeting Abstract May 2003

ARNm Expression of TFF1 Peptide after Refractive Surgery

P.O. Lafontaine; N. Buron; M. Soulie; E. Solary; A.M. Bron; C. Garcher

Invest. Ophthalmol. Vis. Sci.. 2003; 44(13):3778. doi:

Advertisement